Lab Notes: Helius launches flagship product in U.S.; Virpax reports positive preclinical results for seizure drug

A Plymouth Meeting firm may seek an additional regulatory approval for its sleep disorder medicine.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.